Search research articles
Contact Us
Filters
Showing results (321-330 of 348) with videos related to
Page
of 35
Sort By:
Nature Medicine
|
May 31, 2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A Braun, Yue Hou, Ziad Bakouny, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
Meenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
J Bryan Iorgulescu, Prafulla C Gokhale, Maria C Speranza, et al.
Cancer Discovery
|
October 1, 2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
Esra A Akbay, Shohei Koyama, Julian Carretero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial
Nourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.
Nature
|
November 28, 2014
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M Gubin, Xiuli Zhang, Heiko Schuster, et al.
Nature Communications
|
February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
Molecular Cancer
|
March 16, 2024
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
Yufei Wang, Alicia Buck, Brandon Piel, et al.
Cancer Discovery
|
February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
Shengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.
Cancer Discovery
|
June 28, 2017
Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition
Carlos R Gil Del Alcazar, Sung Jin Huh, Muhammad B Ekram, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 348) with videos related to
Sort By:
Page
of 35
Nature Medicine
|
May 31, 2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A Braun, Yue Hou, Ziad Bakouny, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
Meenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
J Bryan Iorgulescu, Prafulla C Gokhale, Maria C Speranza, et al.
Cancer Discovery
|
October 1, 2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
Esra A Akbay, Shohei Koyama, Julian Carretero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial
Nourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.
Nature
|
November 28, 2014
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M Gubin, Xiuli Zhang, Heiko Schuster, et al.
Nature Communications
|
February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
Molecular Cancer
|
March 16, 2024
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
Yufei Wang, Alicia Buck, Brandon Piel, et al.
Cancer Discovery
|
February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
Shengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.
Cancer Discovery
|
June 28, 2017
Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition
Carlos R Gil Del Alcazar, Sung Jin Huh, Muhammad B Ekram, et al.
Page
of 35